Short Interest in SanBio Company Limited (OTCMKTS:SNBIF) Declines By 15.4%

SanBio Company Limited (OTCMKTS:SNBIF) was the target of a large drop in short interest in April. As of April 15th, there was short interest totalling 443,500 shares, a drop of 15.4% from the March 31st total of 524,500 shares. Based on an average trading volume of 200 shares, the short-interest ratio is currently 2,217.5 days.

SanBio Stock Performance

Shares of SNBIF opened at C$11.32 on Friday. The firm has a 50 day simple moving average of C$8.55 and a two-hundred day simple moving average of C$6.04. SanBio has a one year low of C$4.65 and a one year high of C$11.32.

About SanBio

SanBio Company Limited develops, produces, and sells regenerative cell medicines for the central nervous system. The company develops SB623 that has completed a phase 2 clinical trial to treat traumatic brain injury in the United States and Japan. Its research pipeline products also comprise SB623 for ischemic and hemorrhagic strokes, age-related macular degeneration, retinitis pigments, Parkinson’s disease, spinal cord injury, and Alzheimer’s disease; SB618 for peripheral nerve damage; SB308 for muscular dystrophy disease; MSC1 for cancer; and MSC2 for inflammatory disease and optic neuritis.